Nuvation Bio

Quarterly Financials

Values in thousands 2024-12-31 2024-09-30 2024-06-30 2024-03-31
Revenue
$5,711
$727
$1,435
$264
Gross Profit
1,495
-788
-156
-58
EBITDA
-49,137
-41,090
-462,116
-20,141
EBIT
-49,356
-41,252
-462,360
-20,199
Net Income
-49,445
-41,210
-462,492
-14,792
Net Change In Cash
5,711
727
1,435
264
Free Cash Flow
-46,289
-31,233
-37,324
-15,729
Cash
35,723
30,036
34,285
34,510
Basic Shares
336,934
273,565
244,738
219,048

Annual Financials

Values in thousands 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Revenue
$7,873
$0
$0
$0
Gross Profit
795
-222
-484
-368
EBITDA
-566,915
-99,600
-119,535
-89,347
EBIT
-567,598
-99,822
-120,019
-89,715
Net Income
-567,939
-75,802
-88,664
-79,734
Net Change In Cash
7,873
0
0
0
Cost of Revenue
-31,324
102,668
Free Cash Flow
-130,575
-68,068
-96,478
-68,472
Cash
35,723
42,649
101,099
132,423
Basic Shares
268,772
218,880
216,721
197,887

Earnings Calls

Quarter EPS
2024-12-31
-$0.11
2024-09-30
-$0.15
2024-06-30
-$0.15
2024-03-31
-$0.07